6533b851fe1ef96bd12a98b0
RESEARCH PRODUCT
Artiflex Toric Phakic Intraocular Lens Implantation in Congenital Nystagmus
César Albarrán-diegoTeresa Ferrer-blascoSantiago García-lázaroGonzalo MuñozLurdes Beldasubject
medicine.medical_specialtygenetic structuresbusiness.industrymedicine.medical_treatmentToric phakic intraocular lensNystagmusPhakic intraocular lenseye diseasesMyopic astigmatismOphthalmologyLeft eyeNystagmuslcsh:OphthalmologyOphthalmologic examinationlcsh:RE1-994OphthalmologyRefractive surgeryMedicineIn patientPublished: August 2011sense organsmedicine.symptomRefractive surgerybusinessCongenital nystagmusdescription
Case: A 44-year-old woman with congenital nystagmus and myopic astigmatism in both eyes who was submitted to phakic intraocular lens (pIOL) implantation. Methods: Full ophthalmologic examination including refractive status, corrected (CDVA) and uncorrected (UCVA) monocular and binocular visual acuities, ocular motility, slit-lamp evaluation, tonometry and fundoscopy before and after implantation of toric pIOLs (Artiflex; Ophtec BV, The Netherlands) in both eyes. Results: Preoperative logMAR CDVA were 0.699 and 0.420 in the right and left eye, respectively. Three months after surgery, logMAR UCVA were 0.398 and 0.182, reaching binocular logMAR UCVA of 0.132. There were no changes in nystagmus characteristics after surgery. Conclusions: pIOL implantation may be a safe and suitable treatment to correct high refractive errors in patients with congenital nystagmus. Significant improvement in CDVA and UCVA can be achieved.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2011-08-01 | Case Reports in Ophthalmology |